XenoGesis and BioAscent forge alliance to offer enhanced integrated drug discovery services

May 16, 2018

XenoGesis and BioAscent Discovery Limited have announced a collaboration to offer an enhanced range of integrated drug discovery services, including medicinal chemistry, biology and DMPK. Clients from across the globe will be able to access highly experienced teams specialising in these core drug discovery disciplines. Both companies have outstanding drug discovery and development credentials. Together they are dedicated to delivering tailored solutions for clients and a more personalised service which ranges from target evaluation through to candidate nomination and predicted clinical pharmacokinetics and dose. XenoGesis is a fast-growing provider of DMPK services, quantitative bioanalysis, in vitro pharmacology and modelling and simulation ...

Read More

Designing Smart Integrated Drug Delivery Systems

Jan 4, 2018

Wearable drug delivery technology is a good example of how drug delivery technology providers continue to stay ahead of the curve. In his piece, Graham Reynolds of Global Biologics, West Pharmaceutical Services, looks into today’s advanced drug delivery systems, complex pieces of technology that can incorporate innovative and intuitive features that can make it easier for patients to self-administer critical medications. ...

Read More